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Aberrant insulin signaling results in an impaired ability to clear glucose from the 
bloodstream, which progresses to type II diabetes mellitus once insulin stimulation no 
longer results in a significant decrease in blood glucose levels. GLUT4 is the insulin-
responsive glucose transporter which, upon insulin stimulation, translocates to the plasma 
membrane where it is embedded, promoting glucose uptake in muscle and adipose tissue. 
The potential causes for insufficient glucose uptake are numerous because the insulin 
signaling pathway has many intermediates and targets, including myosin II. It is known 
that myosin II is necessary for proper glucose uptake, though the mechanism by which 
myosin II promotes glucose uptake is unknown. We aim to determine if myosin II is 
functioning to stabilize the actin tether which is used as a track by secretory GLUT4 
vesicles to reach the plasma membrane. GLUT4 vesicle trafficking along the actin tether 
is accomplished via association of the GLUT4 vesicle with the cargo carrying, actin-
based motor proteins, myosin Va and myosin Ic.  Here we demonstrate that myosin II is 
necessary to localize myosin Va and myosin Ic with GLUT4 and F-actin at the plasma 
membrane. These findings demonstrate that myosin II is necessary to localize these 
proteins in an insulin-stimulated acto-myosin protein complex which supports GLUT4 
translocation to the plasma membrane. These events may be critical regulatory nodes 
which could yield therapeutic targets helpful in treating those with type II diabetes. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 Insulin-stimulated glucose uptake in adipose tissue and skeletal muscle is 
important for whole-body glucose homeostasis. Diabetes mellitus, characterized by 
increased blood glucose levels, is a disease affecting approximately 10% of Americans1. 
There are two types of diabetes mellitus, type I and type II. Type I diabetes is an 
autoimmune disorder wherein the β cells of the pancreas, the cells which synthesize 
insulin, are destroyed by the body’s immune system. Thus, no insulin-stimulated glucose 
uptake can occur without exogenous insulin administration. Type II diabetes differs from 
type 1 diabetes in that insulin is produced, however, the tissues which are insulin-
responsive, adipose and muscle tissue, become unresponsive to insulin stimulation. This 
is brought about by deficiencies in insulin signaling. In adipocytes and myocytes, insulin 
binds to its receptor activating several intracellular pathways, most notably the 
PI3K/AKT pathway. This pathway facilitates the translocation of vesicles containing the 
insulin responsive glucose transporter, GLUT4, to the plasma membrane where it is 
embedded and promotes glucose uptake2 (Figure 1). 
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Figure 1. Schematic of Insulin-stimulated Glucose Uptake via Activation of the 
PI3K/AKT Signaling Pathway. 
 
 
 Before GLUT4 vesicle fusion with the plasma membrane can occur, the actin 
cytoskeleton must undergo remodeling. In adipocytes, few stress fibers are present thus 
the vast majority of filamentous actin, F-actin, resides directly underneath the plasma 
membrane at the cell cortex. By virtue of its location within adipocytes, actin acts as an 
important regulator of vesicle exocytosis in two ways. First, extensions of cortical actin, 
known as actin tethers, reach into the cytosol and have been implicated in acting as tracks 
for secretory cargo to reach the plasma membrane after reaching the end of 
microtubules3. Second, F-actin must be reorganized in order to allow for vesicle 
exocytosis as the actin cytoskeleton acts as a physical barrier preventing membranes of 
secretory vesicles from fusing with the plasma membrane4.  
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Myosin II is an important protein regulating the actin cytoskeleton as it binds 
cortical actin and provides the necessary contractile force to drive various cytoskeletal-
dependent functions such as cytokinesis, cellular migration, and the maintenance of 
cortical tension5,6. The role of myosin II in recent years has expanded to include 
mediating vesicle exocytosis as exemplified in the myosin II-dependent release of 
catecholamines from murine chromaffin cells7. We have shown previously that GLUT4 
mediated glucose uptake is reduced in the presence of the myosin II specific inhibitor, 
blebbistatin8. These findings further suggest that myosin II is necessary for vesicle 
exocytosis. What is not known is the molecular mechanism(s) by which myosin II 
mediates GLUT4 vesicle exocytosis. 
 
 
Figure 2. Schematic of Translocation of GSVs from Microtubules to the Actin 
Tether. 
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GLUT4 Trafficking 
GLUT4 trafficking is a highly regulated, multi-step process3,9. In the basal 
(unstimulated) state, GLUT4 is present in the cytoplasm embedded in the membrane of 
intracellular GLUT4 storage vesicles (GSVs) in a perinuclear region. Upon insulin 
stimulation, GSVs translocate to the plasma membrane on microtubules via microtubule-
associated kinesin motor proteins, KIF3b and KIF5a10,11. Upon approaching the plasma 
membrane, GSVs disassociate from the microtubule and translocate to actin tethers 
extending approximately 200 nm into the cytoplasm9. Two myosin motor proteins, 
myosin Va and myosin Ic, have been implicated in regulating GSV translocation to the 
cell cortex along actin tethers12–15 (Figure 2).  
In the basal state, myosin Va is diffusely localized throughout the cytosol; 
however, with insulin stimulation myosin Va translocates and colocalizes with GLUT4 at 
or near the plasma membrane. Complimentary immunoprecpitation studies revealed a 
physical association of myosin Va with GSVs. Additionally, anti-myosin Va siRNA 
inhibited GLUT4 translocation and reduced glucose uptake, further suggesting myosin 
Va is responsible for promoting anterograde GSV translocation and ultimately GLUT4-
dependent glucose uptake12.  
Like myosin Va, myosin Ic shows distinct localization patterns within 3T3-L1 
adipocytes13,16. In the basal state, myosin Ic shows a punctate patterning in the cytoplasm. 
With insulin stimulation, myosin Ic has also been shown to colocalize with GLUT4 and 
bind F-actin at the plasma membrane. Additionally, myosin Ic associates with the 
exocyst, a “y”-shaped, octomeric protein complex responsible for tethering secretory 
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vesicles to the plasma membrane14,17. This suggests a role for myosin Ic in targeting 
GSVs to the exocyst complex for exocytosis. Inhibition of myosin Ic via expression of a 
myosin Ic dominant inhibitory cargo domain results in a marked decrease of GLUT4 
embedded in the plasma membrane. Furthermore, the role for myosin Ic in vesicle 
exocytosis has been established in other cell lines, specifically alveolar type II cells 
which demonstrate that a knockdown of myosin Ic expression decreases surfactant 
vesicle exocytosis18.  
Once the GSV arrives at the cell cortex via myosin Va and myosin Ic, proteins 
embedded in the GSV form a complex with plasma membrane bound proteins forming 
what is known as the SNARE complex. The SNARE complex brings both membranes 
together to mediate a zipper-like fusion of the GSV membrane and the plasma 
membrane19. This results in GLUT4 insertion in the plasma membrane. 
 
 
Myosin II 
 Alongside myosin Ic and Va, the conventional myosin, myosin II, has been 
implicated in promoting GLUT4 vesicle trafficking8,20,21. Myosin II is a hexameric 
protein consisting of two heavy chains which comprise the tail domain, two regulatory 
light chains (RLC), and two essential light chains (ELC), together comprising the neck 
domain22 (Figure 3). Myosin II also has an ATPase head domain that interacts directly 
with actin to mediate actin binding23. 
Two forms of myosin II are expressed within mammals: muscle and non-muscle 
myosin II. The more commonly known myosin is muscle myosin II which assembles into 
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bipolar filaments via interactions of many myosin II tail domains. Head domains present 
at each end of the bipolar filaments mediate actin contraction and relaxation in 
sarcomeres, causing contraction and relaxation of entire muscle fibers. In a non-muscle 
cell context, non-muscle myosin II shares the same structure and ability to assemble into 
bipolar filaments as muscle myosin II; however, non-muscle myosin II participates in a 
variety of critical actin cytoskeletal processes ranging from cytokinesis to cell 
migration5,6. Three isoforms of non-muscle myosin II are encoded within mammalian 
genomes, non-muscle myosin II A, B, and C; however, within 3T3-L1 adipocytes only 
the A and B isoforms (referred to hence as myosin IIa and myosin IIb) are 
expressed8,24,25. Within adipocytes, the myosin II isoforms show distinct localization 
patterns. Myosin IIa, under basal conditions, resides at the perinuclear region, much like 
GLUT4. When stimulated by insulin, myosin IIa translocates to the plasma membrane. In 
contrast, myosin IIb is enriched at the cell cortex under basal conditions and remains at 
the cell cortex with insulin stimulation8. 
 
 
Figure 3. Structure and Protein Domains of Myosin II. 
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The Regulatory Role of Myosin IIa in GLUT4 Exocytosis 
 Myosin II is necessary for GLUT4 membrane trafficking during insulin 
stimulation. We have shown in previous studies that the myosin IIa isoform is regulated 
by insulin stimulation. Upon insulin stimulation, the RLC of myosin IIa is 
phosphorylated by myosin light chain kinase (MLCK) which promotes the translocation 
of myosin IIa from the perinuclear region to the plasma membrane. However, the RLC of 
myosin IIb remains unchanged during insulin stimulation. Myosin IIb resides at the cell 
cortex in the basal state and remains at the cell cortex upon insulin stimulation. RLC 
phosphorylation via MLCK also increases myosin II ATPase activity by allowing myosin 
II to linearize from its inactive, bipolar filament assembly incompetent 10S hairpin 
conformation26,27. Prior to myosin IIa translocation, GLUT4 is also stimulated to 
translocate from the perinuclear region to the plasma membrane28. In order for 
appropriate glucose uptake to take place, both GLUT4 and myosin IIa must be recruited 
to the plasma membrane20.  
In a previous study, we treated adipocytes with blebbistatin, a reversible chemical 
inhibitor that inhibits myosin II ATPase activity20,29. Blebbistatin has been shown to be a 
specific myosin II inhibitor with no cross reactivity with myosins I, V, or X30. Treatment 
with blebbistatin prevented adequate glucose uptake despite GLUT4 translocation to the 
plasma membrane which appeared to be a consequence of a decrease in GLUT4 insertion 
in the plasma membrane. This was demonstrated by staining adipocytes with an antibody 
against an exofacial domain of GLUT428. Thus, myosin II is critical for the insulin-
stimulated insertion of GLUT4 in the plasma membrane. 
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Cortical Actin and Actin Tethers 
 Though myosin II appears to be vital for proper GLUT4 exocytosis, myosin II 
cannot exert contractile forces on the cytoskeleton necessary for GLUT4 exocytosis 
without binding to actin. Within adipocytes, there exists an enrichment of cortical F-
actin. It has been shown that with insulin stimulation, F-actin at the plasma membrane 
increases suggesting a role for actin filaments in GLUT4 translocation20. To investigate 
this potential role, Kanzaki et. al exposed adipocytes to compounds which either prevent 
actin depolymerization or inhibit actin polymerization, enhancing cortical actin and 
reducing cortical actin, respectively4. Both states of the cortical actin network prevented 
adequate glucose uptake making a case for the necessity of a dynamic actin cytoskeleton 
which can polymerize in specific areas to act as a scaffold for proteins which increase 
GLUT4 exocytosis efficiency. Actin tethers are an example of such scaffolds.  
Actin tethers are extensions of cortical actin which can bridge distances within 
100 to 200 nm of the plasma membrane. This is much greater than the effective tethering 
distance of the exocyst complex which is approximately 15 nm3. These tethers reach into 
the cytosol towards microtubules which carry GSVs towards the cell periphery. As 
described earlier, it is at this point that the microtubule-bound kinesin proteins carrying 
GSVs “hand off” the GSVs to the actin-based motor proteins myosin Va and Ic for 
advancement to the cell cortex along the actin tether. Therefore, it is necessary to have a 
rich, dynamic acto-myosin cytoskeleton to promote GLUT4 exocytosis.  
This was further demonstrated by Stall et al where it was shown that with insulin 
stimulation there is an enhanced co-localization of F-actin and myosin IIa at the plasma 
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membrane. With insulin stimulation, an increase in F-actin at the plasma membrane was 
also observed. When treated with blebbistatin, insulin-induced F-actin enrichment and 
co-localization with myosin IIa at the plasma membrane decreased20. This suggests a role 
for myosin IIa in stabilizing F-actin which accumulates at the plasma membrane under 
insulin-stimulated conditions. Indeed, in Dictyostelium it has been shown that myosin II 
acts to cross link actin filaments, a process necessary to maintain cortical tension and 
proper cell morphology. Dictyostelium lacking myosin II are more susceptible to extreme 
cell body deformation, including fragmentation, when chemotaxing through a restrictive 
environment31–33. 
 
 
A 
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Figure 4. Proposed Mechanism of Myosin II Stabilization of Actin Tethers. A) 
Proposed model of myosin II stabilization of actin tethers at the plasma membrane 
promoting GLUT4 exocytosis. B) Proposed inhibition of myosin II prevents the 
formation of stable actin tethers, inhibiting GLUT4 exocytosis. 
 
 
These insights into the rich cortical actin network of adipocytes, the role of actin 
tethers as “tracks” for anterograde vesicle movement, and the necessity for myosin IIa in 
GLUT4 exocytosis demonstrate a case supporting myosin IIa and F-actin tethers as 
critical regulators of GLUT4 exocytosis. However, what remains unknown is the 
mechanism by which myosin II is able to promote GLUT4 exocytosis. More specifically, 
it is unknown in which vesicle trafficking events, such as tethering or docking and fusion, 
myosin II is participating.  Given the available evidence, a model emerges in which 
myosin II functions to stabilize actin tethers at the plasma membrane (Figure 4 A/B). 
Thus, adipocytes stimulated by insulin have increasing levels of F-actin at the plasma 
membrane. Upon insulin stimulation, myosin IIa and GLUT4 are independently 
stimulated to translocate to the plasma membrane.  Myosin IIa stabilizes actin filaments 
B 
11 
 
at the plasma membrane, more specifically actin tethers, which allows cargo-binding, 
actin-based motor proteins such as myosin Va and Ic to facilitate GSV procession 
towards the plasma membrane. In the present study, we investigate the role of myosin II 
in stabilizing actin tethers in 3T3-L1 adipocytes, promoting GLUT4 exocytosis. 
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CHAPTER II 
MATERIALS AND METHODS 
 
 
Materials 
 3T3-L1 pre-adipocytes (CL-173) were purchased from ATCC. Dulbecco’s 
Modified Eagle Medium (11995) and fetal bovine serum (26140-079) were purchased 
from Gibco. Bovine calf serum was purchased from Hyclone (SH20072.03). Insulin 
(15500-1G) and 3-isobutyl 1-methylxanthine (I5879) were obtained from Sigma. 
Antibodies for GLUT4 (sc-1606), Myosin Va (sc-365986), Myosin Ic (sc-136544), and 
HRP conjugated donkey anti-goat secondary antibody (sc-2020) were purchased from 
Santa Cruz Biotechnology. Agarose Beads conjugated with Protein A+G (sc-2003) was 
also purchased from Santa Cruz Biotechnology. Actin antibody was purchased from 
Abcam (ab3280). Myosin IIa (M8064) and Myosin IIb (M7939) antibodies were obtained 
from Sigma. Alexa-flour 488 conjugated rabbit anti-mouse antibody (A-11059), Alexa-
fluor 594 conjugated donkey anti-mouse antibody (A-11058), Alexa-fluor 488 donkey 
anti-rabbit antibody (A-21206), Alexa-fluor 594 goat anti-rabbit antibody (R37117), and 
Texas Red-X Phalloidin (T7571) was obtained from Invitrogen. Blebbistatin (Ab120425) 
was purchased from Abcam.  The enhanced chemiluminescence (ECL) kit (K-12045-
D20) was obtained from Advansta.  
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Cell Culture 
 3T3-L1 preadipocytes were cultured in Dulbeccos’s Modified Eagle Medium 
(DMEM) supplemented with 10% calf serum every two days until confluent. Two days 
after confluency, differentiation was induced by supplementing DMEM with 0.5 mM 3-
isobutyl 1-methylxanthine, 1 µM dexamethasone, 1 µg/ml of insulin and 10% fetal 
bovine serum (FBS). On day 3 after differentiation, media was replaced with 10% FBS + 
DMEM supplemented with 1 µg/ml of insulin. On day 5 and every two days after, the 
media was replaced with 10% FBS + DMEM. Between days 8-10, the cells became fully 
differentiated and were used for experiments. 
 
Immunostaining 
 Day 8-10 differentiated 3T3-L1 adipocytes grown on cover slips were serum 
starved in the presence of 100 uM blebbistatin or vehicle (0.1% DMSO) for 4 hours and 
were left untreated (Basal) or stimulated with 100 nM insulin in the absence of 
blebbistatin (Insulin) or in the presence of blebbistatin (Insulin + Blebbistatin) for 30 
min. Cells were then fixed with 3.7% paraformaldehyde, permeabilized with 0.25% 
Triton X-100 for 5 minutes, and then blocked in a 10% donkey serum - 1x PBS solution. 
Coverslips were incubated with anti-GLUT4 antibody or phalloidin conjugated with 
Texas Red, and either, anti-myosin Va antibody, or anti-myosin 1c antibody. Coverslips 
were subsequently incubated with the appropriate fluorescently labeled secondary 
antibodies. Coverslips were mounted on slides using Dako fluorescent mounting medium 
(S3023). Slides were viewed using fluorescence microscopy using a Keyence BZ-X710 
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Fluorescent Microscope. Additional images were also acquired using confocal 
microscopy via an Olympus IX81 Motorized Inverted Confocal Microscope and 
FLUOVIEW FV500 software. 
 
Co-immunoprecipitation  
 Once adipocytes were serum starved and treated as described in the immuno-
staining section, cells were washed twice with ice-cold 1x PBS and then exposed to lysis 
buffer containing 100 mM NaF, 1 M HEPES, 5 M NaCl, 100 mM EDTA, 70% NP-40, 
100 mM NaPPi, 50% Glycerol, protease inhibitor, and phosphatase inhibitor. Protein 
lysates were collected, rocked for 20 min at 4 oC, then centrifuged at 6000x g for 20 
minutes at 4 oC to pellet insoluble materials. Protein was then incubated with either anti-
myosin IIa antibody or anti-myosin Va antibody overnight at 4 oC. Subsequent incubation 
of protein extract with agarose beads conjugated with protein A/G was performed 
overnight at 4 oC. Samples were then centrifuged for 5 min at 2500x g at 4 oC followed 
by 3 washes with lysis buffer before being stored at -20 oC for subsequent western blot 
analysis. 
 
Western Blot 
 Proteins were extracted from day 8-10 differentiated 3T3-L1 adipocytes as 
described in the immunoprecipitation section. Extracts were heated to 95 oC for 5 minutes 
and subjected to 10% SDS-PAGE and then transferred for 24 hours to a Immobilon-P 
membrane (Millipore IPFL 00010). Proteins were then probed using specific primary and 
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secondary antibodies. Protein bands were visualized using enhanced chemiluminescence 
(ECL) and quantified using densitometric analysis in ImageJ software.  
 
Statistical Analysis 
 Data are expressed as means ± SEM. The significance of differences between 
means, set at P<0.05, was assessed by Student’s t-test (Microsoft Excel). 
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CHAPTER III 
 
RESULTS 
 
 
Previous studies in our lab have shown that myosin II inhibition via blebbistatin 
treatment of adipocytes significantly reduced insulin-stimulated glucose uptake8. 
Previous studies also have shown that myosin II inhibition prevents insulin-stimulated 
GLUT4 vesicle fusion with the plasma membrane28. Together, these results suggest that 
myosin II is necessary for glucose uptake by facilitating the process of GLUT4 
translocation to the plasma membrane, a process which is mediated in part by actin 
tethers. The focus of these studies is to determine if myosin II is functioning to stabilize 
the actin tether which is used as a track by secretory GLUT4 vesicles to reach the plasma 
membrane. GLUT4 vesicle procession along the actin tether is accomplished via 
association of the GLUT4 vesicle with the cargo carrying, actin-based motor proteins, 
myosin Va and myosin Ic.  
 
 
Myosin II Inhibition Reduces Myosin Va Localization with GLUT4 at the Plasma 
Membrane During Insulin Stimulation 
Previous studies have shown that myosin Va is integral to GLUT4 exocytosis and 
glucose uptake in adipocytes12,34. Upon insulin stimulation, myosin Va associates with 
GLUT4 vesicles. Insulin stimulation also induces myosin Va to translocate to the plasma 
membrane and bind F-actin. This suggests that myosin Va translocates to the plasma 
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membrane to facilitate insulin-stimulated glucose uptake by binding and carrying GLUT4 
vesicles to the plasma membrane along actin tethers. To investigate if myosin II is 
stabilizing the actin tether on which myosin Va facilitates GLUT4 translocation, we had 
to first determine if myosin II was necessary to localize myosin Va with GLUT4 during 
insulin stimulation. To that end, mature adipocytes grown on coverslips were serum 
starved for 4 hours with and without blebbistatin and then subsequently stimulated for 30 
minutes with 100 nM insulin alone, insulin and 100 uM blebbistatin, or left untreated. 
A 
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Figure 5. Myosin Va Localization at the Plasma Membrane Decreases with 
Blebbistatin Treatment. Adipocytes were grown on coverslips and serum starved in the 
presence of vehicle (0.1% DMSO) or 100 uM Blebbistatin for 4 hours, and then 
stimulated with or without 100 nM insulin for 30 minutes. Adipocytes on coverslips were 
fixed, permeabilized, and incubated with antibodies against myosin Va and GLUT4. 
Appropriate secondary antibodies conjugated to fluorophores were then applied. A) 
Fluorescence was observed using a Keyence BZ-X Fluorescence Microscope. B-C) Fold 
change in fluorescence intensity at the plasma membrane and in the cytosol was 
quantified using ImageJ and are expressed as percent of vehicle control (basal). Results 
are means +/- SEM of three independent experiments *p<0.05. 
 
B 
C 
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Using fluorescence microscopy (Figure 5A) we observed that in the basal state, 
myosin Va had a cytosolic localization. Upon insulin stimulation, we found that myosin 
Va redistributes from a mostly cytosolic localization to the plasma membrane. These 
findings agree with previous studies that characterized myosin Va localization before and 
during insulin stimulation12. It is widely known that GLUT4, upon insulin stimulation, 
moves from the perinuclear region to the plasma membrane to facilitate glucose uptake. 
We show that myosin Va and GLUT4 localization at the plasma membrane increased by 
31% and 34% respectively when compared to adipocytes in the basal state (Figure 5B 
and 5C). However, upon myosin II inhibition and insulin treatment, myosin Va and 
GLUT4 translocation to the plasma membrane only increased by 9% and 16%, 
respectively. This is a significant reduction in myosin Va translocation to the plasma 
membrane when compared to insulin stimulation alone. These results suggest that myosin 
II is necessary to localize myosin Va at the plasma membrane as does GLUT4 under 
insulin stimulated conditions. 
 
 
Inhibition of Myosin II Prevents Insulin Stimulated Localization of Myosin Ic and GLUT4 
at the Plasma Membrane 
While myosin Va has been shown to facilitate GLUT4 translocation to the plasma 
membrane, it has also been shown that myosin Ic is a necessary component of the process 
of GLUT4 translocation13,14. Thus, we investigated whether myosin II inhibition affected 
the ability of myosin Ic to localize with GLUT4 at the plasma membrane.  
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Figure 6. Blebbistatin Inhibition of Myosin II Decreases the Levels of Myosin Ic at 
the Plasma Membrane During Insulin Stimulation. Adipocytes were grown on 
coverslips and serum starved in the presence of vehicle (0.1% DMSO) or 100 uM 
Blebbistatin for 4 hours, and then stimulated with or without 100 nM insulin for 30 
minutes. Adipocytes were fixed, permeabilized, and incubated with antibodies against 
myosin Ic and GLUT4. Appropriate secondary antibodies conjugated to fluorophores 
were then applied. A) Fluorescence was observed using a Keyence BZ-X Fluorescence 
Microscope. B) Fold change in fluorescence intensity at the plasma membrane and in the 
cytosol was quantified using ImageJ and are expressed as percent of vehicle control. 
Results are means +/- SEM of three independent experiments. *p<0.05 
 
 
Using fluorescence microscopy (Figure 6A), we have shown that in the basal state 
myosin Ic is localized to the cytosol. Upon insulin stimulation, myosin Ic signal at the 
plasma membrane increases, corroborating previous studies which also find an increase 
in myosin Ic signal at the plasma membrane driven by insulin13,14. Myosin Ic signal at the 
plasma membrane increased by 25% with insulin stimulation (Figure 6B), however, 
inhibition of myosin II reduced the levels of myosin Ic at the plasma membrane when 
B 
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compared to insulin stimulation alone. Myosin Ic was primarily detected in a basal 
localization pattern when treated with blebbistatin and insulin. With insulin and 
blebbistatin co-treatment, myosin Ic presence at the plasma membrane is only increased 
11% from basal, a significant reduction of 14% in myosin Ic translocation when 
compared to insulin stimulation alone. These findings suggest that, as was seen with 
myosin Va, myosin II is necessary to facilitate the insulin-dependent localization of 
myosin Ic with GLUT4 at the plasma membrane. 
 
 
Myosin II Inhibition Reduces the Association of Myosin Ic and Myosin Va with Myosin II 
During Insulin Stimulation 
Immunoprecipitation studies were employed to determine if the ability of myosin 
II to complex with either myosin Ic or myosin Va was decreased during myosin II 
inhibition. It should be noted that blebbistatin is a specific myosin II inhibitor and has 
been shown to have no cross-reactivity with myosins I or V30.  Mature adipocytes were 
serum starved in the presence of 0.1% DMSO or blebbistatin and then treated with 
insulin or left unstimulated (basal). Whole cell lystates were collected from each 
treatment condition and incubated with either myosin Va or myosin IIa antibody for 
immunoprecipitation. 
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Figure 7. Blebbistatin-mediated Inhibition of Myosin II Decreases the Association of 
Myosin Ic with Myosin II During Insulin Stimulation. Adipocytes were serum starved 
in the presence of vehicle (0.1% DMSO) or 100 uM Blebbistatin for 4 hours, and then 
stimulated with or without 100 nM insulin for 30 minutes. Whole cell lysates were 
collected and incubated with myosin IIa antibody overnight with agarose beads 
conjugated with protein A/G. Bound protein was subjected to SDS-PAGE. A) Protein 
was transferred to a membrane and immunoblotted for myosin IIa and myosin Ic. B) Fold 
change in band intensity indicating increased association of protein with myosin IIa was 
quantified using densiometric analysis in ImageJ and are expressed as percent of vehicle 
control. Results are means +/- SEM of three independent experiments. *p<0.05 
 
A 
B 
24 
 
It was observed with myosin IIa immunoprecipitation (Figure 7A) that there was a 
30% increase in association of myosin Ic with myosin IIa during insulin stimulation when 
compared to the basal state (Figure 7B). Surprisingly, with blebbistatin and insulin co-
treatment, myosin Ic association with myosin IIa decreased by 10% when compared to 
the basal state (Figure 7B).  
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Figure 8. Association of Myosin Va with Myosin II Decreases with Inhibition of 
Myosin II. Adipocytes were serum starved in the presence of vehicle (0.1% DMSO) or 
100 uM Blebbistatin for 4 hours, and then stimulated with or without 100 nM insulin for 
30 minutes. Whole cell lysates were collected and incubated with myosin Va Ab 
overnight with agarose beads conjugated with protein A/G. A) Protein was transferred to 
a membrane and immunoblotted for myosin Va, and myosin IIa, B) Fold change in band 
intensity was quantified using densiometric analysis in ImageJ and are expressed as 
percent of vehicle control. Results are means +/- SEM of three independent experiments. 
*p<0.05 
 
 
Myosin Va immunoprecipitation studies (Figure 8 A-B) demonstrated a 55% 
increase in myosin IIa association with myosin Va during insulin stimulation when 
compared to the basal state. Blebbistatin and insulin co-treatment reduced myosin IIa 
association with myosin Va by 75% from basal. A decrease in myosin Va/Ic association 
with myosin II during myosin II inhibition appears to indicate that myosin II is necessary 
to maintain the acto-myosin protein complex promoting GLUT4 translocation of which 
myosin Ic and myosin Va are a part.  
B 
26 
 
During insulin stimulation, F-actin is enriched at the plasma membrane and 
undergoes dynamic reorganizations in order to facilitate the trafficking of GLUT4 
vesicles from intracellular pools to the plasma membrane in adipocytes4. It has been 
shown previously that if myosin II is inhibited during insulin stimulation, F-actin 
enrichment at the plasma membrane decreases which suggests that myosin II is necessary 
for actin filament enrichment20. During myosin II inhibition, it is possible that less actin 
filaments are available for myosin Ic and myosin Va to bind and use as secretory tracks 
for GLUT4 vesicles.  
Thus, in order to determine if myosin II is required to maintain the actin tether on 
which myosin Ic and myosin Va promote GLUT4 translocation, we investigated the 
change in co-localization of myosin Ic and myosin Va with F-actin at the plasma 
membrane during insulin stimulation with and without myosin II inhibition. 
 
 
Inhibition of Myosin II Decreases Insulin Stimulated Co-localization of Myosin Ic with F-
actin at the Plasma Membrane 
 In order to investigate if myosin II is necessary to co-localize cortical F-actin and 
myosin Ic, confocal microscopy was used to visualize myosin Ic and F-actin. F-actin was 
labeled using a Texas Red fluorophore conjugated to phalloidin, a toxin which 
preferentially binds F-actin by intercalating into the spaces between the globular actin 
monomers comprising actin filaments35. Mature adipocytes grown on coverslips were 
serum starved with 0.1% DMSO or 100 uM blebbistatin and subsequently treated with 
100 nM insulin or left unstimulated, as described in the methods section. 
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Figure 9. A Decrease in Myosin Ic Localization at the Plasma Membrane is 
Observed During Insulin Stimulation and Myosin II Inhibition. Adipocytes grown on 
coverslips were serum starved in the presence of vehicle (0.1% DMSO) or 100 uM 
Blebbistatin and subsequently treated with or without insulin. Coverslips were then fixed 
and permeabilized. Subsequently, adipocytes were incubated with primary antibody 
against myosin Ic. Appropriate secondary antibody was applied in addition to Texas Red-
phalloidin to stain F-actin. A) Coverslips were then mounted and visualized using 
confocal microscopy. B-C) Plasma membrane and cytoplasmic fluorescence for myosin 
Ic and actin was measured using ImageJ. The ratio of plasma membrane to cytoplasmic 
fluorescence was normalized to the basal state. Each graph is expressed as the average of 
3 independent experiments +/- SEM. *p<0.05. 
 
 
Upon insulin stimulation there is an increase in fluorescent signal at the plasma 
membrane of myosin Ic and F-actin as observed with confocal microscopy (Figure 9A). 
Our results confirm previous studies indicating that insulin stimulation increases myosin 
Ic translocation to the plasma membrane13,14. Composite images for myosin Ic and F-
actin fluorescence (Figure 9A. g, h, and i) indicate co-localization. Using ImageJ 
fluorescence quantification tools, we determined that actin filament enrichment at the 
C 
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plasma membrane increased by approximately 30% (Figure 9C). These results are in 
agreement with previous studies in our lab which also observed an increase in F-actin at 
the plasma membrane during insulin stimulation. Similarly, myosin Ic enrichment at the 
plasma membrane also increased 37% at the plasma membrane (Figure 9B).  
Upon co-treatment of adipocytes with insulin and blebbistatin, it was observed 
that myosin II inhibition reduced the insulin induced increase in F-actin formation at the 
plasma membrane (Figure 9C). Additionally, a decrease in myosin Ic fluorescence at the 
plasma membrane was also observed upon myosin II inhibition. Co-localization of 
myosin Ic and F-actin at the plasma membrane also appears to decrease under myosin II 
inhibition (Figure 9A. i). When compared to the basal state, F-actin enrichment at the 
plasma membrane only increased by 9% when treated with blebbistatin and insulin 
(Figure 9C). Similarly, myosin Ic translocation to the plasma increased by only 9% when 
treated with insulin and blebbistatin when compared to the basal state (Figure 9B). These 
results indicate that myosin II is necessary to maintain myosin Ic co-localization with F-
actin at the plasma membrane. 
 
 
Myosin II Inhibition Reduces Insulin-induced Myosin Va Co-localization with F-actin at 
the Plasma Membrane 
To investigate if myosin II is necessary to localize myosin Va and F-actin at the 
plasma membrane, adipocytes were serum starved and treated using the same conditions 
as described in the previous section.  
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Figure 10. During Myosin II Inhibition, a Decrease in Myosin Va Localization at the 
Plasma Membrane is Observed Upon Insulin Stimulation When Compared to 
Insulin Stimulation Alone. Adipocytes grown on coverslips were serum starved in the 
presence of vehicle (0.1% DMSO) or 100 uM Blebbistatin and subsequently treated with 
insulin or without insulin. Coverslips were then fixed, permeabilized, and incubated with 
primary antibody against myosin Va followed by the appropriate secondary antibody. A) 
A 
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Coverslips were then mounted and visualized using confocal microscopy. B) Plasma 
membrane and cytoplasmic fluorescence for myosin Va was measured using ImageJ. The 
ratio of plasma membrane to cytoplasmic fluorescence was graphed and normalized to 
the basal state. Each graph is expressed as the average of 3 independent experiments +/- 
SEM. *p<0.05. 
 
 
In the basal state, myosin Va was observed to have primarily a diffuse, cytosolic 
localization; however, upon insulin stimulation an increase in myosin Va fluorescence at 
the plasma membrane was observed (Figure 10A). Our observations corroborate previous 
studies which also find increased levels of myosin Va at the plasma membrane upon 
insulin stimulation12. As seen previously, F-actin fluorescence at the plasma membrane 
also increased with insulin stimulation. When compared to the basal state, myosin Va 
localization at the plasma membrane increased by 51% (Figure 10B).  
Upon myosin II inhibition with blebbistatin, myosin Va only increased by 25% at 
the plasma membrane when compared to the basal state. This is approximately 50% as 
much myosin Va translocation as was observed with insulin stimulation alone. These 
results indicate that, just as was seen with myosin Ic, myosin II is necessary to maintain 
co-localization of myosin Va with F-actin at the plasma membrane. 
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CHAPTER IV 
DISCUSSION 
 
 While the cell signaling events prior to insulin-stimulated GLUT4 translocation 
have been well characterized, the cytoskeletal events prior to GLUT4 vesicle fusion with 
the plasma membrane, such as vesicle tethering, are less well characterized. Even less 
well known is the role myosin II plays during insulin-stimulated GLUT4 vesicle 
tethering. We sought to determine if myosin II stabilizes cortical actin tethers which 
support GLUT4 translocation to the plasma membrane during insulin stimulation.  
In the present study, we demonstrated that myosin II inhibition prevents the 
localization of myosin Ic and GLUT4 at the plasma membrane upon insulin stimulation. 
Myosin Ic translocation to the plasma membrane was reduced upon myosin II inhibition 
from levels observed with insulin alone. GLUT4 also showed a decrease in translocation 
with blebbistatin treatment from insulin alone. This demonstrates that myosin II 
inhibition reduces the insulin-induced translocation of myosin Ic and GLULT4 
suggesting that myosin II is indeed at least necessary to localize myosin Ic and GLUT4 at 
the plasma membrane. Next, we investigated if myosin II was necessary to co-localize 
myosin Ic and F-actin at the plasma membrane. Localization of myosin Ic and F-actin 
during insulin stimulation was observed using confocal microscopy. We observed that 
upon myosin II inhibition, myosin Ic and F-actin localization at the plasma membrane 
decreased from levels observed with insulin stimulation alone. These data show that 
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myosin Ic, GLUT4, and F-actin localize at the plasma membrane in a myosin II-
dependent manner. Since myosin II has been shown previously to stabilizes actin 
filaments31,36, these data suggest that myosin II is able to stabilize F-actin tethers at the 
plasma membrane, creating a stable platform to anchor myosin Ic and myosin Va to 
facilitate GLUT4 translocation to the plasma membrane. 
 Having established that these proteins localize at the plasma membrane together 
in a myosin II-dependent manner, we sought to determine if they also complex together 
in a myosin II-dependent manner. Immunoprecipitation of myosin IIa revealed that 
inhibition of myosin II decreases the ability of myosin Ic to complex with myosin IIa 
during insulin stimulation. Taken together these findings strongly indicate that myosin IIa 
is acting to stabilize the acto-myosin complex which is needed to promote GLUT4 
exocytosis. It is important to note that blebbistatin reduces myosin II ATP-ase activity by 
complexing with myosin II, ADP, and Pi thereby slowing the release of the phosphate 
group after ATP hydrolysis29. During this time, the affinity of the myosin II head for 
actin is lower resulting in destabilized actin filaments. 
Next, we also sought to assess if myosin Va localization and its ability to complex 
with other proteins, such as myosins II and Ic, and GLUT4, was affected by myosin II 
inhibition. Our results show that upon myosin II inhibition, myosin Va localization with 
GLUT4 at the plasma membrane decreased when compared to insulin treatment alone. 
Similarly, myosin Va localization with F-actin at the plasma membrane was decreased 
when myosin II was inhibited. These results suggest that myosin II is necessary to 
localize myosin Va, GLUT4, and F-actin at the plasma membrane. It was next necessary 
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to determine if there are any physical association of these proteins in a complex at the 
plasma membrane. Using immunoprecipitation of myosin Va, we showed that myosin IIa 
association with myosin Va during myosin II inhibition decreased below what is 
observed in the basal state. Myosin II inhibition also abolished the insulin-induced 
association of myosin IIa with myosin Va. These findings demonstrate that myosin IIa 
and myosin Va associate together in a myosin II-dependent manner.  
Interestingly, during blebbistatin treatment, the association of myosin Ic and 
myosin Va with myosin IIa decreased below levels seen in the basal state. This suggests 
that, in the basal state, myosin Ic and Va may possibly associate at low levels with F-
actin near the perinuclear region. Indeed, fluorescence microscopy images show enriched 
myosin Ic and myosin Va near the nucleus. F-actin as visualized by confocal microscopy 
is also found to be perinuclear in the basal state. This low level association of myosin Va 
and Ic with actin filaments is possible as myosin IIa is also localized near the perinuclear 
region where it may be associating with and stabilizing F-actin. Thus, one possible 
explanation for the observed decrease in association of myosin IIa with myosins Va and 
Ic below what is observed in the basal state is that myosin IIa would not be able to 
stabilize perinuclear actin filaments in addition to cortical actin filaments thereby 
reducing the amount of myosin Ic and myosin Va associating with myosin IIa below 
basal levels during myosin II inhibition. 
Our findings corroborate previous evidence demonstrated by our lab which 
supports myosin II as an important regulatory protein promoting the process of GLUT4 
exocytosis. Our lab has previously shown that upon myosin II inhibition in 3T3-L1 
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adipocytes, a variety of effects related to GLUT4 vesicle exocytosis and subsequent 
glucose uptake can be observed. First, glucose uptake is reduced with insulin 
stimulation8. As GLUT4 is the insulin responsive glucose transporter, a reduction in 
glucose uptake is likely due to a decrease in GLUT4 exocytosis which was observed 
during myosin II inhibition 28. Although GLUT4 exocytosis is reduced in a state of 
myosin II inhibition, GLUT4 vesicles still approach the plasma membrane. This suggests 
that the GLUT4 vesicle is able to translocate only so far before an impediment, myosin II 
inhibition, prevents the final steps leading up to vesicle fusion and/or possibly prevents 
the fusion event itself. Our findings suggest that myosin II is promoting GLUT4 
exocytosis by binding and stabilizing cortical actin tethers. Stabilized actin tethers 
provide a robust platform which are able to anchor myosin Ic and myosin Va aiding in 
GLUT4 translocation to the cell periphery. During myosin II inhibition, it is likely that 
actin tethers are compromised, resulting in potentially truncated tethers which bind 
myosin Ic and Va less effectively (Figure 4). This would lead to the observed reduction in 
GLUT4 exocytosis seen in our studies during myosin II inhibition using blebbistatin. 
Moreover, a similar reduction in GLUT4 exocytosis has also been observed in a study by 
Chung et al in which 3T3-L1 adipocytes were transfected with anti-myosin IIa siRNA37.  
 Considering non-muscle myosin II’s role in the cell as a critical structural and 
motor protein associated with the cytoskeleton, it is not surprising that myosin II 
inhibition would have an effect on GLUT4 exocytosis as it has been shown previously 
that a dynamic cytoskeleton is necessary for proper glucose uptake. Upon insulin 
stimulation both F-actin and myosin IIa are enriched at the cell cortex suggesting that 
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myosin IIa may be facilitating changes in the actin cytoskeleton which aid in GLUT4 
exocytosis 4,20. This case is further supported by Fulcher et al who demonstrated that 
myosin IIa is recruited to the plasma membrane specifically during insulin stimulation 
and co-localized with GLUT4 at the plasma membrane 28. Moreover, it has been 
demonstrated that myosin II inhibition decreases the level of insulin-induced F-actin 
enrichment at the plasma membrane 20. In the present study, we also show a reduction in 
the localization of myosin Ic and myosin Va with F-actin at the plasma membrane during 
myosin II inhibition. Together, these data provide further evidence that myosin II may be 
responsible for stabilizing actin tethers since myosin Ic and myosin Va cannot localize 
with F-actin at the plasma membrane when myosin II is inhibited. 
 Having provided evidence that myosin II is necessary to localize and associate 
myosin Ic and myosin Va with both GLUT4 and F-actin at the plasma membrane during 
insulin stimulation, future studies could investigate the localization patterns of myosin Ic 
and myosin Va using more specific methods to inhibit myosin II activity. As discussed 
earlier, myosin II assembles into bipolar filaments. These bipolar filaments bind F-actin 
and facilitate cytoskeletal rearrangements or cross-link F-actin to maintain cytoskeletal 
stability. By expressing myosin II proteins which are assembly incompetent, these 
experiments could be repeated to corroborate the current findings. Additionally, assembly 
incompetent constructs of each isoform of the myosin II heavy chain present in 3T3-L1s 
(myosin IIa and myosin IIb) could be used to determine which isoform contributes to the 
stabilization of actin tethers. Plasmids also exist which can over express non-
phosphorylatable amino acid substitutions in the RLC 38. Without RLC phosphorylation, 
37 
 
myosin II remains in its 10S hairpin conformation preventing myosin II from assuming 
its linearized, assembly competent form 39. Thus, less F-actin stabilization would occur. 
Together, our results give insight into the role of myosin II in supporting GLUT4 
exocytosis. We have determined that myosin II inhibition decreases localization of 
myosin Ic and myosin Va with GLUT4 and F-actin at the plasma membrane. 
Additionally, we have determined that myosin II association with myosin Ic and myosin 
Va decreases with myosin II inhibition. These data suggest that myosin II is necessary to 
localize these proteins in an insulin-induced acto-myosin protein complex which supports 
GLUT4 translocation to the plasma membrane. These findings are important in further 
elucidating the distal events in insulin signaling. These events may be critical regulatory 
nodes which could yield therapeutic targets helpful in treating those with type II diabetes. 
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